David E. Jorden Net Worth & Insider Trades

David E. Jorden - Acting Chief Financial Officer, Plx Pharma Inc

As of June 16, 2017

What is David E. Jorden's Net Worth?

The current estimated net worth of Plx Pharma Inc's Acting Chief Financial Officer, David E. Jorden, is estimated to be about $4.57M . David E. Jorden owns about 151,913 units of Plx Pharma Inc common stock. In the last 2 months at Plx Pharma Inc, David E. Jorden has sold an estimated value of $0 worth.

What is David E. Jorden's Past Insider Trading?

David E. Jorden's largest purchase order was 32,727 units , worth over $225K on June 16, 2017. In total, David E. Jorden has made about 2 transactions over 2 months of their time at Plx Pharma Inc. David E. Jorden usually trades in June and April, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David E. Jorden's' Mailing Address?

  • Mailing address is 2635 Technology Forest Blvd. The Woodlands TX 77381 TX

Plx Pharma Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Michael J. Valentino 2019 $234,375 - - $327,200 - - - $680,325
Michael J. Valentino 2018 $200,000 - - - - - - $300,000
Natasha Giordano 2019 $468,750 - - $865,751 - - $16,000 $1,615,501
Natasha Giordano 2018 $400,000 - - - - - $16,000 $616,000
Rita M. O’Connor 2019 $347,917 - - $505,831 - - $12,500 $1,058,748
Rita M. O’Connor 2018 $300,000 - - - - - $12,500 $462,500
Efthymios Deliargyris 2019 $353,750 - - $245,400 - - $12,500 $801,650
Efthymios Deliargyris 2018 $115,532 - - $157,850 - - $102,167 $432,912
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1497504/000092189520002477/def14a11577002_09252020.htm

What are Plx Pharma Inc's Past Insider Trades?

Plx Pharma Inc's most recent insider trade came on March 16, 2022 by Natasha Giordano who bought 4,100 units worth $14.98K . In the last 5 years, insiders at Plx Pharma Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are Michael Valentino, Executive Chairman,  Natasha Giordano, Chief Executive Officer,  and Rita M. O'Connor, Chief Financial Officer .

PLx Pharma Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1